These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17150962)

  • 41. Localization of the intracellular activity domain of Pasteurella multocida toxin to the N terminus.
    Wilson BA; Ponferrada VG; Vallance JE; Ho M
    Infect Immun; 1999 Jan; 67(1):80-7. PubMed ID: 9864199
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cellular and molecular action of the mitogenic protein-deamidating toxin from Pasteurella multocida.
    Wilson BA; Ho M
    FEBS J; 2011 Dec; 278(23):4616-32. PubMed ID: 21569202
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antigenicity of partial fragments of recombinant Pasteurella multocida toxin.
    Lee J; Woo HJ
    J Microbiol Biotechnol; 2010 Dec; 20(12):1756-63. PubMed ID: 21193834
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pasteurella multocida toxin interaction with host cells: entry and cellular effects.
    Wilson BA; Ho M
    Curr Top Microbiol Immunol; 2012; 361():93-111. PubMed ID: 22552700
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Selective Membrane Redistribution and Depletion of Gαq-Protein by Pasteurella multocida Toxin.
    Clemons NC; Luo S; Ho M; Wilson BA
    Toxins (Basel); 2016 Aug; 8(8):. PubMed ID: 27490568
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Application of intact cell-based NFAT-beta-lactamase reporter assay for Pasteurella multocida toxin-mediated activation of calcium signaling pathway.
    Luo S; Ho M; Wilson BA
    Toxicon; 2008 Mar; 51(4):597-605. PubMed ID: 18190943
    [TBL] [Abstract][Full Text] [Related]  

  • 47.
    Chakraborty S; Kloos B; Harre U; Schett G; Kubatzky KF
    Front Immunol; 2017; 8():185. PubMed ID: 28289415
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CXCL8 Knockout: A Key to Resisting
    Yuan J; Zhao Q; Li J; Wen Y; Wu R; Zhao S; Lang YF; Yan QG; Huang X; Du S; Cao SJ
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791369
    [No Abstract]   [Full Text] [Related]  

  • 49. Pasteurella multocida toxin is a potent inducer of anchorage-independent cell growth.
    Higgins TE; Murphy AC; Staddon JM; Lax AJ; Rozengurt E
    Proc Natl Acad Sci U S A; 1992 May; 89(10):4240-4. PubMed ID: 1584759
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of Pasteurella multocida Toxin on the differentiation of dendritic cells into osteoclasts.
    Chakraborty S; Kloos B; Roetz N; Schmidt S; Eigenbrod T; Kamitani S; Kubatzky KF
    Immunobiology; 2018 Jan; 223(1):142-150. PubMed ID: 29030011
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Auranofin Inhibits the Enzyme Activity of Pasteurella multocida Toxin PMT in Human Cells and Protects Cells from Intoxication.
    Carle S; Brink T; Orth JH; Aktories K; Barth H
    Toxins (Basel); 2017 Jan; 9(1):. PubMed ID: 28098782
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In Vivo Targets of
    Banu A; Lax AJ; Grigoriadis AE
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326543
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunological roles of Pasteurella multocida toxin (PMT) using a PMT mutant strain.
    Kim TJ; Toan NT; Jang EJ; Jung BG; Lee JI; Lee BJ
    J Microbiol; 2007 Aug; 45(4):364-6. PubMed ID: 17846592
    [TBL] [Abstract][Full Text] [Related]  

  • 54. His1205 and His1223 are essential for the activity of the mitogenic Pasteurella multocida toxin.
    Orth JH; Blöcker D; Aktories K
    Biochemistry; 2003 May; 42(17):4971-7. PubMed ID: 12718539
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activation of G
    Ebner JK; König GM; Kostenis E; Siegert P; Aktories K; Orth JHC
    Bone; 2019 Oct; 127():592-601. PubMed ID: 31376533
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The potent mitogen Pasteurella multocida toxin is highly resistant to proteolysis but becomes susceptible at lysosomal pH.
    Smyth MG; Pickersgill RW; Lax AJ
    FEBS Lett; 1995 Feb; 360(1):62-6. PubMed ID: 7875303
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Signaling cascades of Pasteurella multocida toxin in immune evasion.
    Kubatzky KF; Kloos B; Hildebrand D
    Toxins (Basel); 2013 Sep; 5(9):1664-81. PubMed ID: 24064721
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mutation of a putative ADP-ribosylation motif in the Pasteurella multocida toxin does not affect mitogenic activity.
    Ward PN; Higgins TE; Murphy AC; Mullan PB; Rozengurt E; Lax AJ
    FEBS Lett; 1994 Mar; 342(1):81-4. PubMed ID: 8143855
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Involvement of Osteocytes in the Action of
    Heni H; Ebner JK; Schmidt G; Aktories K; Orth JHC
    Toxins (Basel); 2018 Aug; 10(8):. PubMed ID: 30104531
    [No Abstract]   [Full Text] [Related]  

  • 60. Activity of the mitogenic Pasteurella multocida toxin requires an essential C-terminal residue.
    Ward PN; Miles AJ; Sumner IG; Thomas LH; Lax AJ
    Infect Immun; 1998 Dec; 66(12):5636-42. PubMed ID: 9826336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.